Gapping up
In reaction to strong earnings/guidance: HAS +15.8%, CMRE +11.9%, WHR +8%, TWTR +7.3%, LMT +6.7%, HSTM +5.9%, TECK +5.7%, BEDU +5.3%, CDNS +5.3%, BRO +4.9%, PHM +4.3%, ATI +3.8%, ACC +3.6%, KO +3.6%, UTX +3.4%, IRDM +3.3%, CNC +3%, ALSN +2.8%, AXE +2.5%, JBLU +2.3%, BANC +2.2%, PII +2.1%, MINI +1.9%, RRC +1.7%, WAL +1.5%, NUE +0.9%M&A news:
- NOG +4% (announces accretive acquisition in the core of the Williston Basin; assets are expected to be accretive to earnings, cash flow per share)
- MUR +3.5% (to acquire deep water Gulf of Mexico assets from LLOG Exploration Offshore, L.L.C. and LLOG Bluewater Holdings for cash consideration of $1.375 billion)
Other news:
- GNC +9.2% (now offering topical cream products containing cannabidiol, in select retail locations and online in 23 states and the District of Columbia)
- ALDR +8.2% (announces FDA acceptance of BLA for eptinezumab)
- PCG +2.8% (submits updated financing proposal infrastructure investments)
- VCYT +1.8% (ticking higher; received regulatory authorization from the New York State Department of Health to offer the Envisia Genomic Classifier for patients in the state effective immediately)
- DAVA +1.6% (continued strength)
Analyst comments:
- TRVG +4.7% (upgraded to Buy from Neutral at Guggenheim)
- ROKU +2.5% (initiated with Positive rating and $80 tgt at Susquehanna)
- LYFT +2.5% (initiated with a Overweight at JP Morgan; initiated with a Outperform at Raymond James, among others)
- CI +1.4% (initiated with a Buy at UBS)
- SAFM +0.7% (upgraded to Neutral from Sell at Goldman)